A double-blind, randomized, controlled study of two dose strengths of dalfampridine extended release on walking deficits in ischemic stroke

BACKGROUND: Stroke-induced ischemia affects both cortex and underlying white matter. Dalfampridine extended release tablets (D-ER) enhance action potential conduction in demyelinated axons, which may positively affect post-stroke recovery. OBJECTIVE: Based on promising preliminary data, we compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Page, Stephen J., Kasner, Scott E., Bockbrader, Marcia, Goldstein, Mark, Finklestein, Seth P., Ning, MingMing, El-Feky, Waleed H., Wilson, Christina A., Roberts, Holly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592666/
https://www.ncbi.nlm.nih.gov/pubmed/32651338
http://dx.doi.org/10.3233/RNN-201009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592666/
https://www.ncbi.nlm.nih.gov/pubmed/32651338
http://dx.doi.org/10.3233/RNN-201009

Ejemplares similares